降压治疗与卒中二级预防
antihypertensive treatment and secondary prevention of stroke
摘要
高血压是复发性卒中的重要危险因素,卒中后血压在140/80 mmhg以上的患者相对于血压<140/80 mmhg的患者,卒中复发的危险比(hr)为2.4[1].在伴有心血管疾病和多种血管危险因素的患者中,这种风险可能更高.大量临床研究显示,降压药物在起到降压作用的同时也减少卒中复发风险.各种降压药物在临床应用、指南推荐及预后转归等方面存在不同之处.本文就降压治疗在卒中二级预防中的作用予以综述.
出处
《神经病学与神经康复学杂志》
2010年第3期179-184,共6页
Journal of Neurology and Neurorehabilitation
参考文献10
-
1Friday G,,Alter M,Lai SM.Control of hypertension and risk ofstroke recurrence[].Stroke.2002
-
2Kaplan RC,Tirschwell DL,Longstreth WTJr,et al.Blood pressurelevel and outcomes in adults aged 65 and older with prior ischemicstroke[].Journal of the American Geriatrics Society.2006
-
3Diener HC,Sacco R,Yusuf S.et al.Rationale,design and base-line data of a randomized,double-blind,controlled trial comparingtwo antithrombotic regimens(a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel)and telmisartanversus placebo in patients with strok[].Cerebro-vasc Dis.2007
-
4LawMR,Wald NJ,Morris JK,et al.Value of lowdose combinationtreatment with blood pressure lowering drugs:analysis of 354randomized trials[].British Medical Journal.2003
-
5N ICE,BHS.Clinical guideline 34.Hypertension:management ofhypertension in adults in primary care.CG34 Hypertension N ICEguideline(all the recommendations)(Word format),and:CG34Hypertension quick reference guide. http://www.nice.org.uk/guidance/cg34 . 2006
-
6.Trial of secondary prevention with atenolol after transient ischemic at-tack or nondisabling ischemic stroke.The Dutch TIA Trial StudyGroup[].Stroke.1993
-
7Bangalore S,,Sawhney S,Messerli FH.Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension[].Journal of the American College of Cardiology.2008
-
8Bell DS.Optimizing treatment of diabetes and cardiovascular diseasewith combined alpha,beta-blockade[].Current Medical Research and Opinion.2005
-
9Fonseca VA.Effects of beta-blockers on glucose and lipid metabo-lism[].Current Medical Research and Opinion.2010
-
10Gmi澖ski J,Stajszczyk M.Anti-atherosclerotic action of hypotensivedrugs[].Wiadomosci Lekarskie.1996
-
1王明,刘若阳,王菊芬,余存,李朝恩,李丹凤.生物反馈治疗原发性高血压病的临床应用[J].中国行为医学科学,2004,13(6):648-649. 被引量：7
-
2宁洁,刘秀峰.缬沙坦联合硝苯地平治疗高血压的临床分析[J].中国社区医师（医学专业）,2008,10(21):21-21. 被引量：1
-
3韩丹春,李义召,郭洪志,郭春妮.国产尼莫地平注射液治疗急性缺血性脑血管病的临床研究[J].卒中与神经疾病,1995,2(4):185-188. 被引量：3
-
4陈国芳,刘雷婧,平蕾,刘薇薇,周生奎,秦晓凌,庄丽丽,田永芳.尼莫地平注射液对急性高血压脑出血患者血压及疗效的影响[J].现代中西医结合杂志,2014,23(9):991-993. 被引量：19
-
5张晋,陈金和.尼莫地平治疗急性缺血性脑血管病的疗效分析[J].中国医院药学杂志,2001,21(8):485-486. 被引量：1
-
6崔景修,李钢,陈正挪,李成哲,史有立.Analysis of the effect of Xibiling in prevention of cerebrovascular spasm after subarachnoid hemorrhage[J].中国临床康复,2002,6(15):2335-2335.
-
7王丽.维生素类联合干预在H型高血压患者治疗中的作用[J].临床医学研究与实践,2016,1(5):22-22.
-
8李佳伶,霍平,张素华.清栓酶治疗桥脑出血1例报告[J].现代临床医学,1994,25(1):24-24.
-
9急性脑出血可致心脏功能损伤[J].家庭健康（医学科普）,2010(4):56-56.
-
10韩丹春,李义召,赵庆胜,郭春妮.国产尼莫地平注射液治疗急性缺血性脑血管病的临床研究[J].山东医科大学学报,1995,33(4):323-326. 被引量：7
